Bicycle Therapeutics Plc. (BCYC) NASDAQ
$24.90 0.35 (1.43%)
Market Cap: $530.49M
As of 03/28/24 04:00 PM EDT. Market closed.
Bicycle Therapeutics Plc. (BCYC)
NASDAQ
$24.90
0.35 (1.43%)
Market Cap: $530.49M
As of 03/28/24 04:00 PM EDT. Market closed.
bicycle therapeutics is a biotechnology company with big ambitions. we aim to revolutionise the pharmaceutical landscape with our disruptive technology and proprietary bicyclic peptide (bicycle®) product platform and to develop transformational new therapies for patients to improve future treatment options in oncology. bicycles, a new class of small molecular weight drug conjugates for oncology ... read more
bicycle therapeutics is a biotechnology company with big ambitions. we aim to revolutionise the pharmaceutical landscape with our disruptive technology and proprietary bicyclic peptide (bicycle®) product platform and to develop transformational new therapies for patients to improve future treatment options in oncology. bicycles, a new class of small molecular weight drug conjugates for oncology and other diseases, are designed to have superior targeting abilities and to be more efficacious and better tolerated than existing drug conjugate modalities. they combine the properties of several therapeutic entities in a single modality, exhibiting the affinity and selective pharmacology associated with antibodies; the distribution kinetics of small molecules, allowing rapid tumor penetration; and the “tuneable” pharmacokinetic half-life and renal clearance of peptides, sparing cytotoxin-payload derived liver and gastrointestinal toxicity. our unique ip is based on the work of scientific foun read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Thompson Travis Alvin | Chief Accounting Officer | Jan 03, 2024 | Sale | $17.50 | 604 | 10,570 | 23,375 | Jan 04, 2024, 06:36 PM |
Keen Nicholas | Chief Scientific Officer | Jan 03, 2024 | Sale | $17.50 | 2,640 | 46,200 | 63,593 | Jan 04, 2024, 06:34 PM |
Crockett Nigel | Chief Business Officer | Jan 03, 2024 | Sale | $17.50 | 2,643 | 46,253 | 48,716 | Jan 04, 2024, 06:28 PM |
Milnes Alistair | Chief Operating Officer | Jan 03, 2024 | Sale | $17.50 | 2,643 | 46,253 | 73,196 | Jan 04, 2024, 06:27 PM |
Skynner Michael | Chief Technology Officer | Jan 03, 2024 | Sale | $17.50 | 2,643 | 46,253 | 95,839 | Jan 04, 2024, 06:26 PM |
Lee Kevin | Chief Executive Officer | Jan 03, 2024 | Sale | $17.50 | 8,703 | 152,303 | 390,428 | Jan 04, 2024, 06:25 PM |
Thompson Travis Alvin | Chief Accounting Officer | Oct 03, 2023 | Sale | $20.00 | 54 | 1,080 | 7,979 | Oct 05, 2023, 05:50 PM |
Keen Nicholas | Chief Scientific Officer | Oct 03, 2023 | Sale | $20.00 | 272 | 5,440 | 38,233 | Oct 05, 2023, 05:49 PM |
Crockett Nigel | Chief Business Officer | Oct 03, 2023 | Sale | $20.00 | 442 | 8,840 | 29,359 | Oct 05, 2023, 05:48 PM |
Milnes Alistair | Chief Operating Officer | Oct 03, 2023 | Sale | $20.00 | 442 | 8,840 | 36,839 | Oct 05, 2023, 05:47 PM |
Lee Kevin | Chief Executive Officer | Oct 03, 2023 | Sale | $20.00 | 1,470 | 29,400 | 322,131 | Oct 05, 2023, 05:46 PM |
Skynner Michael | Chief Technology Officer | Oct 03, 2023 | Sale | $20.00 | 442 | 8,840 | 70,482 | Oct 05, 2023, 05:46 PM |
Thompson Travis Alvin | Chief Accounting Officer | Jul 03, 2023 | Sale | $25.10 | 61 | 1,531 | 8,033 | Jul 06, 2023, 04:57 PM |
Skynner Michael | Chief Technology Officer | Jul 03, 2023 | Sale | $25.10 | 451 | 11,320 | 70,924 | Jul 06, 2023, 04:53 PM |
Milnes Alistair | Chief Operating Officer | Jul 03, 2023 | Sale | $25.10 | 451 | 11,320 | 37,281 | Jul 06, 2023, 04:52 PM |
Lee Kevin | Chief Executive Officer | Jul 03, 2023 | Sale | $25.10 | 1,498 | 37,600 | 323,601 | Jul 06, 2023, 04:51 PM |
Keen Nicholas | Chief Scientific Officer | Jul 03, 2023 | Sale | $25.10 | 336 | 8,434 | 38,505 | Jul 06, 2023, 04:50 PM |
Crockett Nigel | Chief Business Officer | Jul 03, 2023 | Sale | $25.10 | 451 | 11,320 | 29,801 | Jul 06, 2023, 04:49 PM |
Keen Nicholas | Chief Scientific Officer | Apr 03, 2023 | Sale | $21.11 | 319 | 6,734 | 38,841 | Apr 05, 2023, 04:43 PM |
Skynner Michael | Chief Technology Officer | Apr 03, 2023 | Sale | $21.11 | 447 | 9,436 | 71,375 | Apr 05, 2023, 04:43 PM |
Milnes Alistair | Chief Operating Officer | Apr 03, 2023 | Sale | $21.11 | 447 | 9,436 | 37,732 | Apr 05, 2023, 04:42 PM |
Kalowski Lee | President and CFO | Apr 03, 2023 | Sale | $21.11 | 376 | 7,937 | 30,309 | Apr 05, 2023, 04:41 PM |
Crockett Nigel | Chief Business Officer | Apr 03, 2023 | Sale | $21.11 | 447 | 9,436 | 30,252 | Apr 05, 2023, 04:40 PM |
Lee Kevin | Chief Executive Officer | Apr 03, 2023 | Sale | $21.11 | 1,486 | 31,369 | 325,099 | Apr 05, 2023, 04:39 PM |
Crockett Nigel | Chief Business Officer | Jan 03, 2023 | Sale | $29.06 | 1,801 | 52,337 | 30,699 | Jan 05, 2023, 09:21 PM |
Milnes Alistair | Chief Operating Officer | Jan 03, 2023 | Sale | $29.06 | 1,801 | 52,337 | 38,179 | Jan 05, 2023, 09:19 PM |
Smethurst Dominic | Chief Medical Officer | Jan 03, 2023 | Sale | $29.06 | 1,801 | 52,337 | 36,699 | Jan 05, 2023, 09:18 PM |
Skynner Michael | Chief Technology Officer | Jan 03, 2023 | Sale | $29.06 | 1,801 | 52,337 | 71,822 | Jan 05, 2023, 09:16 PM |
Keen Nicholas | Chief Scientific Officer | Jan 03, 2023 | Sale | $29.06 | 1,817 | 52,802 | 39,160 | Jan 05, 2023, 09:14 PM |
Kalowski Lee | President and CFO | Jan 03, 2023 | Sale | $29.06 | 1,815 | 52,744 | 30,685 | Jan 05, 2023, 09:12 PM |
Lee Kevin | Chief Executive Officer | Jan 03, 2023 | Sale | $29.06 | 6,000 | 174,360 | 326,585 | Jan 05, 2023, 09:06 PM |
Milnes Alistair | Chief Operating Officer | Mar 25, 2022 | Option Exercise | $20.12 | 5,155 | 103,719 | 22,480 | Mar 29, 2022, 04:36 PM |
Keen Nicholas | Chief Scientific Officer | Dec 21, 2021 | Option Exercise | $14.00 | 15,477 | 216,678 | 15,477 | Dec 22, 2021, 09:01 PM |
Legault Pierre | Director | Dec 20, 2021 | Option Exercise | $8.41 | 7,603 | 63,941 | 7,603 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 22, 2021 | Option Exercise | $8.48 | 97,860 | 829,853 | 97,860 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 21, 2021 | Option Exercise | $8.44 | 44,537 | 375,892 | 44,537 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 20, 2021 | Sale | $57.02 | 7,603 | 433,523 | 0 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 22, 2021 | Sale | $58.01 | 97,860 | 5,676,858 | 0 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 21, 2021 | Sale | $57.11 | 44,537 | 2,543,508 | 0 | Dec 22, 2021, 09:00 PM |
Lee Kevin | Chief Executive Officer | Oct 18, 2021 | Sale | $60.00 | 49 | 2,940 | 225,085 | Oct 18, 2021, 06:22 PM |
Lee Kevin | Chief Executive Officer | Oct 15, 2021 | Sale | $60.05 | 320 | 19,216 | 225,134 | Oct 18, 2021, 06:22 PM |
Lee Kevin | Chief Executive Officer | Oct 14, 2021 | Sale | $60.00 | 4,631 | 277,860 | 225,454 | Oct 18, 2021, 06:22 PM |
Lee Kevin | Chief Executive Officer | Oct 11, 2021 | Sale | $53.88 | 5,000 | 269,388 | 230,683 | Oct 13, 2021, 05:28 PM |
Keen Nicholas | Chief Scientific Officer | Oct 05, 2021 | Sale | $45.10 | 2,178 | 98,228 | 0 | Oct 05, 2021, 04:16 PM |
Keen Nicholas | Chief Scientific Officer | Oct 01, 2021 | Sale | $45.00 | 1,188 | 53,460 | 2,178 | Oct 05, 2021, 04:16 PM |
Smethurst Dominic | Chief Medical Officer | Sep 23, 2021 | Option Exercise | $18.55 | 6,000 | 111,300 | 6,000 | Sep 27, 2021, 04:53 PM |
Keen Nicholas | Chief Scientific Officer | Sep 16, 2021 | Sale | $45.01 | 1,955 | 87,995 | 3,366 | Sep 17, 2021, 04:47 PM |
Keen Nicholas | Chief Scientific Officer | Sep 15, 2021 | Sale | $45.00 | 3,000 | 135,000 | 5,321 | Sep 17, 2021, 04:47 PM |
Kalowski Lee | President and CFO | Sep 02, 2021 | Option Exercise | $9.82 | 10,000 | 98,200 | 10,000 | Sep 03, 2021, 04:49 PM |
Kalowski Lee | President and CFO | Sep 02, 2021 | Sale | $40.00 | 10,000 | 400,000 | 0 | Sep 03, 2021, 04:49 PM |
Keen Nicholas | Chief Scientific Officer | Sep 02, 2021 | Sale | $40.00 | 10,000 | 400,000 | 8,321 | Sep 03, 2021, 04:47 PM |
Lee Kevin | Chief Executive Officer | Sep 01, 2021 | Option Exercise | $14.00 | 22,890 | 320,460 | 267,170 | Sep 03, 2021, 04:46 PM |
Lee Kevin | Chief Executive Officer | Sep 02, 2021 | Sale | $40.00 | 5,000 | 200,000 | 235,085 | Sep 03, 2021, 04:46 PM |
Lee Kevin | Chief Executive Officer | Sep 01, 2021 | Sale | $37.21 | 27,085 | 1,007,897 | 258,979 | Sep 03, 2021, 04:46 PM |
Lee Kevin | Chief Executive Officer | Aug 31, 2021 | Option Exercise | $14.00 | 10,420 | 145,880 | 255,505 | Aug 31, 2021, 05:29 PM |
Lee Kevin | Chief Executive Officer | Aug 27, 2021 | Option Exercise | $14.00 | 1,808 | 25,312 | 246,893 | Aug 31, 2021, 05:29 PM |
Lee Kevin | Chief Executive Officer | Aug 27, 2021 | Sale | $36.02 | 1,808 | 65,124 | 245,085 | Aug 31, 2021, 05:29 PM |
Lee Kevin | Chief Executive Officer | Aug 31, 2021 | Sale | $36.33 | 11,225 | 407,763 | 245,552 | Aug 31, 2021, 05:29 PM |
Kalowski Lee | President and CFO | Aug 27, 2021 | Option Exercise | $8.73 | 7,950 | 69,403 | 7,950 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 26, 2021 | Option Exercise | $8.76 | 550 | 4,818 | 550 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 27, 2021 | Sale | $35.15 | 7,950 | 279,443 | 0 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 26, 2021 | Sale | $35.04 | 550 | 19,272 | 0 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 23, 2021 | Option Exercise | $1.60 | 7,500 | 12,000 | 7,500 | Aug 25, 2021, 05:45 PM |
Kalowski Lee | President and CFO | Aug 23, 2021 | Sale | $33.02 | 7,500 | 247,650 | 0 | Aug 25, 2021, 05:45 PM |
Kalowski Lee | President and CFO | Jul 29, 2021 | Option Exercise | $1.63 | 12,500 | 20,375 | 12,500 | Jul 30, 2021, 06:21 PM |
Kalowski Lee | President and CFO | Jul 29, 2021 | Sale | $31.51 | 12,500 | 393,823 | 3,504 | Jul 30, 2021, 06:21 PM |
Lee Kevin | Chief Executive Officer | Jul 23, 2021 | Option Exercise | $14.00 | 4,782 | 66,948 | 249,867 | Jul 27, 2021, 07:08 PM |
Lee Kevin | Chief Executive Officer | Jul 26, 2021 | Option Exercise | $14.00 | 100 | 1,400 | 245,185 | Jul 27, 2021, 07:08 PM |
Lee Kevin | Chief Executive Officer | Jul 23, 2021 | Sale | $36.02 | 4,782 | 172,248 | 245,085 | Jul 27, 2021, 07:08 PM |
Lee Kevin | Chief Executive Officer | Jul 26, 2021 | Sale | $36.00 | 100 | 3,600 | 245,085 | Jul 27, 2021, 07:08 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 917 | 31,185 | 38,708 | Jul 20, 2021, 04:17 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 12 | 402 | 39,625 | Jul 20, 2021, 04:17 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 43,378 | 1,475,182 | 1,831,671 | Jul 20, 2021, 04:17 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 588 | 19,698 | 1,875,049 | Jul 20, 2021, 04:17 PM |
Keen Nicholas | Chief Scientific Officer | Jul 14, 2021 | Sale | $35.00 | 10,000 | 350,000 | 18,321 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 16, 2021 | Option Exercise | $14.00 | 609 | 8,526 | 245,694 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 15, 2021 | Option Exercise | $14.00 | 21,970 | 307,580 | 267,055 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 16, 2021 | Sale | $34.00 | 609 | 20,706 | 245,085 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 15, 2021 | Sale | $34.28 | 21,970 | 753,132 | 245,085 | Jul 16, 2021, 06:27 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 43,378 | 1,475,182 | 1,831,671 | Jul 15, 2021, 07:03 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 588 | 19,698 | 1,875,049 | Jul 15, 2021, 07:03 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 917 | 31,185 | 38,708 | Jul 15, 2021, 07:03 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 12 | 402 | 39,625 | Jul 15, 2021, 07:03 PM |
Crockett Nigel | Chief Business Officer | Jul 13, 2021 | Option Exercise | $11.84 | 72,701 | 860,433 | 72,701 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 12, 2021 | Option Exercise | $11.72 | 7,028 | 82,380 | 7,028 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 13, 2021 | Sale | $32.44 | 72,701 | 2,358,362 | 3,121 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 12, 2021 | Sale | $32.03 | 7,028 | 225,107 | 0 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 14, 2021 | Option Exercise | $14.00 | 8,331 | 116,634 | 259,550 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 13, 2021 | Option Exercise | $14.00 | 35,446 | 496,244 | 290,180 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 12, 2021 | Option Exercise | $14.00 | 1,936 | 27,104 | 256,670 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 13, 2021 | Sale | $32.97 | 38,961 | 1,284,680 | 268,201 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 12, 2021 | Sale | $32.04 | 1,936 | 62,029 | 254,734 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 14, 2021 | Sale | $34.34 | 14,465 | 496,726 | 256,908 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 06, 2021 | Option Exercise | $9.82 | 271 | 2,661 | 271 | Jul 08, 2021, 05:22 PM |
Crockett Nigel | Chief Business Officer | Jul 06, 2021 | Sale | $32.00 | 271 | 8,672 | 0 | Jul 08, 2021, 05:22 PM |
Lee Kevin | Chief Executive Officer | May 07, 2021 | Option Exercise | $14.00 | 5,604 | 78,456 | 260,338 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | May 06, 2021 | Option Exercise | $14.00 | 1,716 | 24,024 | 256,450 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | May 07, 2021 | Sale | $32.23 | 5,604 | 180,617 | 254,734 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | May 06, 2021 | Sale | $32.14 | 1,716 | 55,152 | 254,734 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | Apr 26, 2021 | Option Exercise | $14.00 | 14,545 | 203,630 | 273,345 | Apr 28, 2021, 04:45 PM |
Lee Kevin | Chief Executive Officer | Apr 27, 2021 | Option Exercise | $14.00 | 6,636 | 92,904 | 261,370 | Apr 28, 2021, 04:45 PM |
Lee Kevin | Chief Executive Officer | Apr 26, 2021 | Sale | $31.28 | 18,611 | 582,144 | 268,630 | Apr 28, 2021, 04:45 PM |
Lee Kevin | Chief Executive Officer | Apr 27, 2021 | Sale | $30.70 | 6,636 | 203,728 | 255,092 | Apr 28, 2021, 04:45 PM |
Legault Pierre | Director | Apr 08, 2021 | Option Exercise | $8.74 | 24,838 | 217,084 | 24,838 | Apr 09, 2021, 04:36 PM |
Legault Pierre | Director | Apr 08, 2021 | Sale | $31.71 | 24,838 | 787,588 | 12,338 | Apr 09, 2021, 04:36 PM |
Legault Pierre | Director | Apr 05, 2021 | Option Exercise | $8.83 | 162 | 1,430 | 162 | Apr 07, 2021, 07:22 PM |
Legault Pierre | Director | Apr 05, 2021 | Sale | $31.07 | 162 | 5,033 | 0 | Apr 07, 2021, 07:22 PM |
Keen Nicholas | Chief Scientific Officer | Mar 31, 2021 | Sale | $30.00 | 10,000 | 300,000 | 28,321 | Apr 02, 2021, 04:45 PM |
Legault Pierre | Director | Mar 31, 2021 | Option Exercise | $8.78 | 10,000 | 87,800 | 10,000 | Apr 02, 2021, 04:44 PM |
Legault Pierre | Director | Mar 31, 2021 | Sale | $30.00 | 10,000 | 300,000 | 0 | Apr 02, 2021, 04:44 PM |
Legault Pierre | Director | Mar 17, 2021 | Option Exercise | $8.85 | 7,784 | 68,888 | 7,784 | Mar 19, 2021, 04:48 PM |
Legault Pierre | Director | Mar 17, 2021 | Sale | $29.00 | 7,784 | 225,736 | 0 | Mar 19, 2021, 04:48 PM |
Legault Pierre | Director | Mar 12, 2021 | Option Exercise | $8.86 | 2,216 | 19,634 | 2,216 | Mar 16, 2021, 07:42 PM |
Legault Pierre | Director | Mar 12, 2021 | Sale | $29.00 | 2,216 | 64,264 | 0 | Mar 16, 2021, 07:42 PM |
Keen Nicholas | Chief Scientific Officer | Mar 15, 2021 | Sale | $28.00 | 217 | 6,076 | 38,321 | Mar 16, 2021, 07:41 PM |
Keen Nicholas | Chief Scientific Officer | Mar 12, 2021 | Sale | $28.50 | 9,783 | 278,767 | 38,821 | Mar 16, 2021, 07:41 PM |
Lee Kevin | Chief Executive Officer | Feb 05, 2021 | Sale | $31.00 | 100 | 3,100 | 258,800 | Feb 09, 2021, 05:28 PM |
Lee Kevin | Chief Executive Officer | Jan 20, 2021 | Sale | $31.88 | 1,185 | 37,779 | 259,351 | Jan 21, 2021, 04:34 PM |
Lee Kevin | Chief Executive Officer | Jan 19, 2021 | Sale | $29.26 | 5,000 | 146,290 | 260,556 | Jan 21, 2021, 04:34 PM |
Kalowski Lee | President and CFO | Jan 19, 2021 | Option Exercise | $1.59 | 15,000 | 23,850 | 15,000 | Jan 21, 2021, 04:29 PM |
Kalowski Lee | President and CFO | Jan 19, 2021 | Sale | $30.00 | 15,000 | 450,000 | 0 | Jan 21, 2021, 04:29 PM |
Kalowski Lee | President and CFO | Jan 14, 2021 | Option Exercise | $1.60 | 10,000 | 16,000 | 10,000 | Jan 15, 2021, 04:44 PM |
Kalowski Lee | President and CFO | Jan 14, 2021 | Sale | $25.00 | 10,000 | 250,000 | 0 | Jan 15, 2021, 04:44 PM |
Lee Kevin | Chief Executive Officer | Jan 15, 2021 | Sale | $27.01 | 5,000 | 135,050 | 265,085 | Jan 15, 2021, 04:40 PM |
Lee Kevin | Chief Executive Officer | Jan 14, 2021 | Sale | $25.00 | 5,000 | 125,000 | 270,085 | Jan 15, 2021, 04:40 PM |
Kalowski Lee | President and CFO | Dec 01, 2020 | Option Exercise | $1.56 | 7,500 | 11,700 | 7,500 | Dec 03, 2020, 08:53 PM |
Kalowski Lee | President and CFO | Dec 01, 2020 | Sale | $22.50 | 7,500 | 168,750 | 0 | Dec 03, 2020, 08:53 PM |
Kalowski Lee | President and CFO | Nov 27, 2020 | Option Exercise | $1.56 | 530 | 827 | 530 | Nov 30, 2020, 04:42 PM |
Kalowski Lee | President and CFO | Nov 27, 2020 | Sale | $20.00 | 530 | 10,600 | 0 | Nov 30, 2020, 04:42 PM |
Kalowski Lee | President and CFO | Nov 25, 2020 | Option Exercise | $1.56 | 9,781 | 15,258 | 9,781 | Nov 25, 2020, 08:31 PM |
Kalowski Lee | President and CFO | Nov 23, 2020 | Option Exercise | $1.56 | 17,189 | 26,815 | 17,189 | Nov 25, 2020, 08:31 PM |
Kalowski Lee | President and CFO | Nov 25, 2020 | Sale | $20.07 | 9,781 | 196,305 | 0 | Nov 25, 2020, 08:31 PM |
Kalowski Lee | President and CFO | Nov 23, 2020 | Sale | $19.83 | 17,189 | 340,805 | 213 | Nov 25, 2020, 08:31 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Jul 15, 2020 | Sale | $19.40 | 3,147 | 61,045 | 1,910,609 | Sep 18, 2020, 12:04 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Jul 14, 2020 | Sale | $19.27 | 1,597 | 30,781 | 1,913,678 | Sep 18, 2020, 12:04 PM |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 10% Owner | May 28, 2019 | Buy | $14.00 | 364,286 | 5,100,004 | 1,957,961 | Jun 03, 2019, 05:15 PM |
Cambridge Innovation Capital (Jersey) Ltd | 10% Owner | May 29, 2019 | Buy | $14.00 | 314,286 | 4,400,004 | 1,751,437 | May 31, 2019, 05:12 PM |
Novartis Bioventures Ltd | 10% Owner | May 28, 2019 | Buy | $14.00 | 168,630 | 2,360,820 | 1,769,641 | May 30, 2019, 09:27 PM |
NG CAROLYN | Director | May 27, 2019 | Buy | $14.00 | 571,429 | 8,000,006 | 571,429 | May 30, 2019, 09:27 PM |
SVLSF V, LLC | 10% Owner | May 28, 2019 | Buy | $14.00 | 377,732 | 5,288,248 | 1,875,637 | May 30, 2019, 09:26 PM |
SVLSF V, LLC | 10% Owner | May 28, 2019 | Buy | $14.00 | 7,983 | 111,762 | 39,637 | May 30, 2019, 09:26 PM |
Anstey Michael | Director | May 28, 2019 | Buy | $14.00 | 314,286 | 4,400,004 | 1,751,437 | May 30, 2019, 09:26 PM |
BINGHAM KATE | Director | May 28, 2019 | Buy | $14.00 | 7,983 | 111,762 | 39,637 | May 30, 2019, 09:26 PM |
BINGHAM KATE | Director | May 28, 2019 | Buy | $14.00 | 377,732 | 5,288,248 | 1,875,637 | May 30, 2019, 09:26 PM |
HARLAND DEBORAH | Director | May 28, 2019 | Buy | $14.00 | 385,714 | 5,399,996 | 1,915,275 | May 30, 2019, 09:25 PM |
GLAXOSMITHKLINE PLC | Director | May 28, 2019 | Buy | $14.00 | 385,714 | 5,399,996 | 1,915,275 | May 30, 2019, 05:47 PM |
Owner | Relationship | Date | Value($) |
Thompson Travis Alvin | Chief Accounting Officer | 01/03/2024 | 10,570 |
Keen Nicholas | Chief Scientific Officer | 01/03/2024 | 46,200 |
Crockett Nigel | Chief Business Officer | 01/03/2024 | 46,253 |
Milnes Alistair | Chief Operating Officer | 01/03/2024 | 46,253 |
Skynner Michael | Chief Technology Officer | 01/03/2024 | 46,253 |
Lee Kevin | Chief Executive Officer | 01/03/2024 | 152,303 |
Thompson Travis Alvin | Chief Accounting Officer | 10/03/2023 | 1,080 |
Keen Nicholas | Chief Scientific Officer | 10/03/2023 | 5,440 |
Crockett Nigel | Chief Business Officer | 10/03/2023 | 8,840 |
Milnes Alistair | Chief Operating Officer | 10/03/2023 | 8,840 |
Lee Kevin | Chief Executive Officer | 10/03/2023 | 29,400 |
Skynner Michael | Chief Technology Officer | 10/03/2023 | 8,840 |
Thompson Travis Alvin | Chief Accounting Officer | 07/03/2023 | 1,531 |
Skynner Michael | Chief Technology Officer | 07/03/2023 | 11,320 |
Milnes Alistair | Chief Operating Officer | 07/03/2023 | 11,320 |
Lee Kevin | Chief Executive Officer | 07/03/2023 | 37,600 |
Keen Nicholas | Chief Scientific Officer | 07/03/2023 | 8,434 |
Crockett Nigel | Chief Business Officer | 07/03/2023 | 11,320 |
Keen Nicholas | Chief Scientific Officer | 04/03/2023 | 6,734 |
Skynner Michael | Chief Technology Officer | 04/03/2023 | 9,436 |
Milnes Alistair | Chief Operating Officer | 04/03/2023 | 9,436 |
Kalowski Lee | President and CFO | 04/03/2023 | 7,937 |
Crockett Nigel | Chief Business Officer | 04/03/2023 | 9,436 |
Lee Kevin | Chief Executive Officer | 04/03/2023 | 31,369 |
Crockett Nigel | Chief Business Officer | 01/03/2023 | 52,337 |
Milnes Alistair | Chief Operating Officer | 01/03/2023 | 52,337 |
Smethurst Dominic | Chief Medical Officer | 01/03/2023 | 52,337 |
Skynner Michael | Chief Technology Officer | 01/03/2023 | 52,337 |
Keen Nicholas | Chief Scientific Officer | 01/03/2023 | 52,802 |
Kalowski Lee | President and CFO | 01/03/2023 | 52,744 |
Lee Kevin | Chief Executive Officer | 01/03/2023 | 174,360 |
Milnes Alistair | Chief Operating Officer | 03/25/2022 | 103,719 |
Keen Nicholas | Chief Scientific Officer | 12/21/2021 | 216,678 |
Legault Pierre | Director | 12/20/2021 | 63,941 |
Legault Pierre | Director | 12/22/2021 | 829,853 |
Legault Pierre | Director | 12/21/2021 | 375,892 |
Legault Pierre | Director | 12/20/2021 | 433,523 |
Legault Pierre | Director | 12/22/2021 | 5,676,858 |
Legault Pierre | Director | 12/21/2021 | 2,543,508 |
Lee Kevin | Chief Executive Officer | 10/18/2021 | 2,940 |
Lee Kevin | Chief Executive Officer | 10/15/2021 | 19,216 |
Lee Kevin | Chief Executive Officer | 10/14/2021 | 277,860 |
Lee Kevin | Chief Executive Officer | 10/11/2021 | 269,388 |
Keen Nicholas | Chief Scientific Officer | 10/05/2021 | 98,228 |
Keen Nicholas | Chief Scientific Officer | 10/01/2021 | 53,460 |
Smethurst Dominic | Chief Medical Officer | 09/23/2021 | 111,300 |
Keen Nicholas | Chief Scientific Officer | 09/16/2021 | 87,995 |
Keen Nicholas | Chief Scientific Officer | 09/15/2021 | 135,000 |
Kalowski Lee | President and CFO | 09/02/2021 | 98,200 |
Kalowski Lee | President and CFO | 09/02/2021 | 400,000 |
Keen Nicholas | Chief Scientific Officer | 09/02/2021 | 400,000 |
Lee Kevin | Chief Executive Officer | 09/01/2021 | 320,460 |
Lee Kevin | Chief Executive Officer | 09/02/2021 | 200,000 |
Lee Kevin | Chief Executive Officer | 09/01/2021 | 1,007,897 |
Lee Kevin | Chief Executive Officer | 08/31/2021 | 145,880 |
Lee Kevin | Chief Executive Officer | 08/27/2021 | 25,312 |
Lee Kevin | Chief Executive Officer | 08/27/2021 | 65,124 |
Lee Kevin | Chief Executive Officer | 08/31/2021 | 407,763 |
Kalowski Lee | President and CFO | 08/27/2021 | 69,403 |
Kalowski Lee | President and CFO | 08/26/2021 | 4,818 |
Kalowski Lee | President and CFO | 08/27/2021 | 279,443 |
Kalowski Lee | President and CFO | 08/26/2021 | 19,272 |
Kalowski Lee | President and CFO | 08/23/2021 | 12,000 |
Kalowski Lee | President and CFO | 08/23/2021 | 247,650 |
Kalowski Lee | President and CFO | 07/29/2021 | 20,375 |
Kalowski Lee | President and CFO | 07/29/2021 | 393,823 |
Lee Kevin | Chief Executive Officer | 07/23/2021 | 66,948 |
Lee Kevin | Chief Executive Officer | 07/26/2021 | 1,400 |
Lee Kevin | Chief Executive Officer | 07/23/2021 | 172,248 |
Lee Kevin | Chief Executive Officer | 07/26/2021 | 3,600 |
BINGHAM KATE | Director | 07/14/2021 | 31,185 |
BINGHAM KATE | Director | 07/13/2021 | 402 |
BINGHAM KATE | Director | 07/14/2021 | 1,475,182 |
BINGHAM KATE | Director | 07/13/2021 | 19,698 |
Keen Nicholas | Chief Scientific Officer | 07/14/2021 | 350,000 |
Lee Kevin | Chief Executive Officer | 07/16/2021 | 8,526 |
Lee Kevin | Chief Executive Officer | 07/15/2021 | 307,580 |
Lee Kevin | Chief Executive Officer | 07/16/2021 | 20,706 |
Lee Kevin | Chief Executive Officer | 07/15/2021 | 753,132 |
BINGHAM KATE | Director | 07/14/2021 | 1,475,182 |
BINGHAM KATE | Director | 07/13/2021 | 19,698 |
BINGHAM KATE | Director | 07/14/2021 | 31,185 |
BINGHAM KATE | Director | 07/13/2021 | 402 |
Crockett Nigel | Chief Business Officer | 07/13/2021 | 860,433 |
Crockett Nigel | Chief Business Officer | 07/12/2021 | 82,380 |
Crockett Nigel | Chief Business Officer | 07/13/2021 | 2,358,362 |
Crockett Nigel | Chief Business Officer | 07/12/2021 | 225,107 |
Lee Kevin | Chief Executive Officer | 07/14/2021 | 116,634 |
Lee Kevin | Chief Executive Officer | 07/13/2021 | 496,244 |
Lee Kevin | Chief Executive Officer | 07/12/2021 | 27,104 |
Lee Kevin | Chief Executive Officer | 07/13/2021 | 1,284,680 |
Lee Kevin | Chief Executive Officer | 07/12/2021 | 62,029 |
Lee Kevin | Chief Executive Officer | 07/14/2021 | 496,726 |
Crockett Nigel | Chief Business Officer | 07/06/2021 | 2,661 |
Crockett Nigel | Chief Business Officer | 07/06/2021 | 8,672 |
Lee Kevin | Chief Executive Officer | 05/07/2021 | 78,456 |
Lee Kevin | Chief Executive Officer | 05/06/2021 | 24,024 |
Lee Kevin | Chief Executive Officer | 05/07/2021 | 180,617 |
Lee Kevin | Chief Executive Officer | 05/06/2021 | 55,152 |
Lee Kevin | Chief Executive Officer | 04/26/2021 | 203,630 |
Lee Kevin | Chief Executive Officer | 04/27/2021 | 92,904 |
Lee Kevin | Chief Executive Officer | 04/26/2021 | 582,144 |
Lee Kevin | Chief Executive Officer | 04/27/2021 | 203,728 |
Legault Pierre | Director | 04/08/2021 | 217,084 |
Legault Pierre | Director | 04/08/2021 | 787,588 |
Legault Pierre | Director | 04/05/2021 | 1,430 |
Legault Pierre | Director | 04/05/2021 | 5,033 |
Keen Nicholas | Chief Scientific Officer | 03/31/2021 | 300,000 |
Legault Pierre | Director | 03/31/2021 | 87,800 |
Legault Pierre | Director | 03/31/2021 | 300,000 |
Legault Pierre | Director | 03/17/2021 | 68,888 |
Legault Pierre | Director | 03/17/2021 | 225,736 |
Legault Pierre | Director | 03/12/2021 | 19,634 |
Legault Pierre | Director | 03/12/2021 | 64,264 |
Keen Nicholas | Chief Scientific Officer | 03/15/2021 | 6,076 |
Keen Nicholas | Chief Scientific Officer | 03/12/2021 | 278,767 |
Lee Kevin | Chief Executive Officer | 02/05/2021 | 3,100 |
Lee Kevin | Chief Executive Officer | 01/20/2021 | 37,779 |
Lee Kevin | Chief Executive Officer | 01/19/2021 | 146,290 |
Kalowski Lee | President and CFO | 01/19/2021 | 23,850 |
Kalowski Lee | President and CFO | 01/19/2021 | 450,000 |
Kalowski Lee | President and CFO | 01/14/2021 | 16,000 |
Kalowski Lee | President and CFO | 01/14/2021 | 250,000 |
Lee Kevin | Chief Executive Officer | 01/15/2021 | 135,050 |
Lee Kevin | Chief Executive Officer | 01/14/2021 | 125,000 |
Kalowski Lee | President and CFO | 12/01/2020 | 11,700 |
Kalowski Lee | President and CFO | 12/01/2020 | 168,750 |
Kalowski Lee | President and CFO | 11/27/2020 | 827 |
Kalowski Lee | President and CFO | 11/27/2020 | 10,600 |
Kalowski Lee | President and CFO | 11/25/2020 | 15,258 |
Kalowski Lee | President and CFO | 11/23/2020 | 26,815 |
Kalowski Lee | President and CFO | 11/25/2020 | 196,305 |
Kalowski Lee | President and CFO | 11/23/2020 | 340,805 |
GLAXOSMITHKLINE PLC | 10% Owner | 07/15/2020 | 61,045 |
GLAXOSMITHKLINE PLC | 10% Owner | 07/14/2020 | 30,781 |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 10% Owner | 05/28/2019 | 5,100,004 |
Cambridge Innovation Capital (Jersey) Ltd | 10% Owner | 05/29/2019 | 4,400,004 |
Novartis Bioventures Ltd | 10% Owner | 05/28/2019 | 2,360,820 |
NG CAROLYN | Director | 05/27/2019 | 8,000,006 |
SVLSF V, LLC | 10% Owner | 05/28/2019 | 5,288,248 |
SVLSF V, LLC | 10% Owner | 05/28/2019 | 111,762 |
Anstey Michael | Director | 05/28/2019 | 4,400,004 |
BINGHAM KATE | Director | 05/28/2019 | 111,762 |
BINGHAM KATE | Director | 05/28/2019 | 5,288,248 |
HARLAND DEBORAH | Director | 05/28/2019 | 5,399,996 |
GLAXOSMITHKLINE PLC | Director | 05/28/2019 | 5,399,996 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BAKER BROS. ADVISORS LP | 4,823,598 | 0.96% | 169.42% | Other |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,650,320 | 4.45% | 28.75% | Growth, Growth At A Reasonable Price |
CANDRIAM S.C.A. | 869,258 | 0.11% | -30.64% | Other |
SUVRETTA CAPITAL MANAGEMENT, LLC | 914,476 | 0.75% | -9.55% | Growth At A Reasonable Price |
RA CAPITAL MANAGEMENT, L.P. | 800,000 | 0.23% | No change | Other |
BLACKROCK INC. | 501,623 | 0.00023% | 158.46% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 448,753 | 0.2% | Exited | Other |
PLATINUM INVESTMENT MANAGEMENT LTD | 362,080 | 0.27% | 26.83% | Growth At A Reasonable Price, Value |
UBS OCONNOR LLC | 125,000 (Call) | 0.02% | 431.91% | Value |
RENAISSANCE TECHNOLOGIES LLC | 105,500 | 0.00295% | 28.66% | Other |
UBS OCONNOR LLC | 73,601 | 0.1% | -5.52% | Value |
GEODE CAPITAL MANAGEMENT, LLC | 18,837 | 0.00004% | 9.88% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View